• Skip to main content

DistilGovHealth

DistilNFO GovHealth Advisory

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

House Democratic Caucus Chairman Announces Support for ‘Medicare for All’

Share:

September 18, 2019

Rep. Hakeem Jeffries (D-N.Y.) announced Wednesday that he is cosponsoring “Medicare for All” legislation in the House, giving a boost to the legislation from a high-ranking House Democrat.

Jeffries is the second-highest-ranking House Democrat to back Medicare for All, after Rep. Ben Ray Luján (D-N.M.), who announced his support in June.

But while Luján is looking to leave the House by running for Senate, Jeffries’s backing is important because he is seen as a potential future Speaker of the House once current Speaker Nancy Pelosi (D-Calif.) retires.

Jeffries stressed that the Affordable Care Act must be strengthened and that Democrats must fight GOP efforts to attack it.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“However, given the enduring nature of our healthcare access and affordability crisis, more must be done,” Jeffries said.

In addition to backing the full-scale Medicare for All bill from Rep. Pramila Jayapal (D-Wash.), Jeffries also announced that he is co-sponsoring more moderate approaches, such as a public option bill known as “Medicare X.”

The top three House Democrats, including Pelosi, have declined to support Medicare for All, instead emphasizing strengthening the Affordable Care Act.

In another show of support for the progressive wing of the Democratic caucus, Jeffries is cosponsoring a far-reaching bill to lower drug prices from Rep. Lloyd Doggett (D-Texas.)

That measure is favored by progressives over the the alternative drug pricing bill that Pelosi’s office is working on and that is expected to be released later this month.

The Doggett bill would allow the government to strip drug companies of their monopolies if they refused to negotiate a reasonable price with the government, a step some moderate House Democrats view as too drastic.

Jeffries said Democrats are “united behind the principle of universal access to high quality and affordable healthcare for all.”

“There are several pathways to achieve this objective, including implementation of a single-payer system or the adoption of a robust public option,” he added.

Date: September 18, 2019

Source: The Hill

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Personalized Health Experience Pavilion to debut at HIMSS19Personalized Health Experience Pavilion to debut at HIMSS19
  • Platform launched to enhance China’s community-level healthcare servicesPlatform launched to enhance China’s community-level healthcare services
  • Sens. Demand AMCA, Quest, LabCorp Explain Failure to Detect BreachSens. Demand AMCA, Quest, LabCorp Explain Failure to Detect Breach
  • An industry on the brink of exponential change: Health in 2040An industry on the brink of exponential change: Health in 2040
  • Trump says He’s Working on Health Insurance Executive Order on Pre-existing Conditions
  • Growing health care spending in ChinaGrowing health care spending in China

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications